Navigation Links
Ronald DePinho, M.D., selected for prestigious Agilent Technologies Thought Leader Award
Date:3/29/2013

HOUSTON Pancreatic cancer is one the deadliest and hardest to treat cancers. In recognition of his leadership of an innovative translational research program targeted at pancreatic cancer, Ronald DePinho, M.D., president of The University of Texas MD Anderson Cancer Center, was selected for the prestigious Agilent Thought Leader Award.

The Thought Leader Award recognizes researchers whose discoveries represent fundamental advances in the life sciences. DePinho, one of only three awardees in 2012, was selected for his research into pancreatic cancer metabolomics. To further promote DePinho's work, the award provides instrumentation and support to examine the metabolic flux that occurs in the earliest stages of the cancer.

Metabolomics analyzes the physiology of the cell, providing a snapshot of cellular energy stores, as well as metabolic precursors and products. Unlocking and targeting the secrets of the cancer metabolism is a powerful therapeutic strategy, as metabolism is a critical cellular process inherent to cancer cell survival.

DePinho's lab recently reported in the journal Cell a study that leverages metabolomic and transcriptome analysis. This work was the first to link a genetic mutation in the Kras gene to both pancreatic cancer initiation and the subsequent manipulation of metabolic pathways that support tumor growth and progression.

Altered cellular metabolism has long been acknowledged as a hallmark of cancer, but until recently technology couldn't identify discrete and targetable metabolic transformations, aberrations unique to cancer cells. Cancer cells have radically different metabolic properties from the tissue of origin. They require more energy and cellular building blocks to support not only rapid growth, but also survival, as they face harsh conditions from cellular assaults.

DePinho's research group, along with scientists from MD Anderson's Institute for Applied Cancer Science (IAC
'/>"/>

Contact: Hilary Graham
hngraham@mdanderson.org
713-794-4383
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. UT MD Anderson President Ronald DePinho elected to National Academy of Sciences
2. Renowned Cosmetic and Plastic Surgeon, Ronald L. Moy, M.D. to Present at Upcoming AACS Meeting on TriPollar, a Breakthrough in Radio Frequency Technology
3. California Body Care Supports USO Tribute Show at Ronald Reagan Library
4. Edith Mitchell, M.D., FACP, named 2012 recipient of ASCO Humanitarian Award
5. ASH awards Timothy J. Ley, M.D., with 2012 E. Donnall Thomas Lecture and Prize
6. ASH honors Bruce R. Blazar, M.D., and Carl H. June, M.D., with 2012 Ernest Beutler Lecture and Prize
7. ASH honors David Ginsburg, M.D., and Richard Aster, M.D., with 2012 Henry M. Stratton Medal
8. Penn Medicines Daniel J. Rader, M.D., receives AHAs Clinical Research Prize
9. Richard Mayeux, M.D., M.S., elected Fellow of AAAS
10. Corita Grudzen, M.D., named a practice change leader to improve health care for older adults
11. Tripp, D.O, F.A.C.O.O.G., Adelstein, D.O, F.A.C.O.O.G., MacFarlane, M.D., F.A.C.O.G., Vardo, D.O, F.A.C.O.G., & Abisla, A.N.P., Receive InTone Specialist Certification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... Two recent studies indicate that previously untreated ... more abused as children than those without these disorders. And ... ADHD children reduces their otherwise higher risk of later ... causation. , Since over 25% of the population suffer from ... and best treatment for these disorders so as to prevent ...
(Date:7/22/2014)... A new and technologically unique procedure ... results that are surprising even the most skeptical plastic ... with radio frequency, ThermiTight has been dubbed “InjectableRF” because ... skin to “inject” heat to the tissues which cause ... treatment solution for skin laxity produces results in weeks, ...
(Date:7/21/2014)... cancer cells could boost the effectiveness of chemotherapy to ... new study reports. , Scientists at The Institute of ... engineered version of the virus used to vaccinate against ... isolated limb perfusion chemotherapy given directly to blood ... alternative to amputation was more effective in rats ...
(Date:7/21/2014)... 22, 2014 Recently, Stwd.co.uk, a popular supplier ... wedding dresses. Additionally, the company’s chief executive officer has stated ... prices, up to 58% off. , “All our new and ... offer is launched to bring huge benefits to worldwide customers. ... cheap wedding outfits. By the way, we offer custom made ...
(Date:7/21/2014)... As reported by CBS Local Pittsburgh ... Raise Addiction Awareness (7/15), thrill-seeking participants raised $100,000 to ... building in Downtown Philly. 100 people, including some well-known ... Westin Convention Center Hotel. Some of the participants shared ... participated because his son killed himself after a long ...
Breaking Medicine News(10 mins):Health News:New Studies Reporting a Higher Incidence of Child Abuse in ADHD and Dyslexia Suggest a Need for Early Medical Treatment, Notes Dr. Harold Levinson 2Health News:New Studies Reporting a Higher Incidence of Child Abuse in ADHD and Dyslexia Suggest a Need for Early Medical Treatment, Notes Dr. Harold Levinson 3Health News:New Studies Reporting a Higher Incidence of Child Abuse in ADHD and Dyslexia Suggest a Need for Early Medical Treatment, Notes Dr. Harold Levinson 4Health News:New Minimally Invasive Procedure, ThermiTight, “Injects” Radio Frequency to Treat Skin Laxity 2Health News:Viral therapy could boost limb-saving cancer treatment 2Health News:Viral therapy could boost limb-saving cancer treatment 3Health News:2014 Cheap Wedding Dresses, Newest Items Offered by Professional Company Stwd.co.uk 2Health News:100 People Climb Down Building to Raise Drug Addiction Awareness in Philadelphia 2Health News:100 People Climb Down Building to Raise Drug Addiction Awareness in Philadelphia 3
... The Healthcare Group at Frost ... Quarterly Analyst Briefing Presentation on the Pharmaceutical CRM Market ... 4 p.m. GMT. (Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO )2008 has ... CRM market. The pharmaceutical industry is adopting a cautious ...
... Day is opportunity to highlight advances for chronic condition; third FDA-approved ... ... 27, 2009 -- Each new treatment that becomes available is a ... according to the National Fibromyalgia Association (NFA), which is ...
... Solutions has announced the release of VitalCenter, a business continuity solution ... electronic health records to provide patient care. , ... ... to their patients, charts, even when the EHR is unavailable. ...
... April 27, 2009The American Urological Association (AUA) today issued ... issued by other major groups about prostate cancer ... be offered to well-informed, men aged 40 years or ... 10 years. The PSA test, as well as how ...
... April 26, 2009) A team of scientists at ... at Princess Margaret Hospital and international collaborators have discovered ... that could be included in new clinical trials that ... The findings, published online today in Nature Medicine ...
... 2009Tadalafil may improve lower urinary tract symptoms in men ... San Antonia and Indianapolis will present these findings during ... Association (AUA). , In this study, researchers randomly ... older than 40 years and at least a six ...
Cached Medicine News:Health News:Frost & Sullivan: The Pharmaceutical Customer Relationship Management Market - What are the Emerging Trends and Opportunities? 2Health News:Frost & Sullivan: The Pharmaceutical Customer Relationship Management Market - What are the Emerging Trends and Opportunities? 3Health News:Treatment Options Increase For Millions with Fibromyalgia 2Health News:Treatment Options Increase For Millions with Fibromyalgia 3Health News:Galen Healthcare Solutions Launches Electronic Health Record Downtime Solution 2Health News:AUA counters mainstream recommendations with new best practice statement on PSA testing 2Health News:AUA counters mainstream recommendations with new best practice statement on PSA testing 3Health News:AUA counters mainstream recommendations with new best practice statement on PSA testing 4Health News:Scientists discover how to improve immune response to cancer at Princess Margaret Hospital 2
(Date:7/21/2014)...  PowerVision, Inc., a medical device company developing ... announced that Douglas D. Koch , M.D., ... and Professor of Ophthalmology, at Baylor College of ... As a recipient of several ... Lifetime Achievement award, Koch will join the distinguished ...
(Date:7/21/2014)... July 21, 2014  AVT, Inc. (OTC Markets: ... retailing, micro-stores, custom vending machines and kiosks, commented ... medicine dispensing systems, which can be used by ... marijuana dispensaries. AVT,s newly designed systems provide for ... and regulated products. "We are getting ...
(Date:7/21/2014)... July 21, 2014  Avanir Pharmaceuticals, Inc. (NASDAQ: ... and Drug Administration (FDA) accepted the company,s Investigational New ... the safety and efficacy of AVP-786, Avanir,s next generation ... AVP-786 for the adjunctive treatment of major depressive disorder ... "The endorsement of this Phase II study ...
Breaking Medicine Technology:PowerVision Appoints Ophthalmology Thought Leader Douglas D. Koch, M.D. to its Scientific Advisory Board 2PowerVision Appoints Ophthalmology Thought Leader Douglas D. Koch, M.D. to its Scientific Advisory Board 3PowerVision Appoints Ophthalmology Thought Leader Douglas D. Koch, M.D. to its Scientific Advisory Board 4Technology Driving Cannabis Industry 2Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 2Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 3Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 4Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 5
... base with vacuum stage, porous vacuum plate, reservoir ... instructions. The Model 785 vacuum blotter quickly ... agarose gel onto a nylon membrane. Because it ... nucleic acid samples can be separated on a ...
... regulator. The Model 785 vacuum blotter ... from an agarose gel onto a nylon ... min for transfer, the nucleic acid samples ... to a membrane, and the hybridization reaction ...
Inquire...
... proven electrophoretic transfer apparatus incorporating state-of-the-art plate electrodes ... allows for a very close positioning of the ... power source such as a battery charger, creates ... exceptionally rapid and exact electrophoretic transfer. ...
Medicine Products: